LOS ANGELES, April 27, 2018 -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the May 1, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Ulta Beauty, Inc. (“Ulta Beauty” or the “Company”) (NASDAQ: ULTA) securities between March 30, 2016 and February 23, 2018, inclusive (the “Class Period”).
To obtain information or actively participate in the class action, please visit the Ulta Beauty page on our website at www.glancylaw.com/case/ulta-beauty-inc.
Investors suffering losses on their Ulta Beauty investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to [email protected].
On February 9, 2018, media outlets reported allegations that the Company engaged in the “widespread and surreptitious” practice of repacking returned cosmetics and re-shelving them alongside unblemished products to sell at full price. On this news, Ulta’s share price fell $9.07, or 4.15%, to close at $209.48 on February 12, 2018, thereby injuring investors.
The complaint filed in this class action alleges that the Company issued false and/or misleading statements and/or failed to disclose that: (1) Ulta Beauty was engaged in the widespread practice of repackaging returned cosmetics and re-shelving them alongside unblemished products to sell at full retail price; and (2) as a result, Ulta Beauty's public statements were materially false and misleading at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of Ulta Beauty during the Class Period you may move the Court no later than May 1, 2018 to ask the Court to appoint you as lead. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay and Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
www.glancylaw.com
[email protected]


Ampol Profit Surges as Refining Margins Hit Record Highs
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
KPMG Australia Cuts 5% of Workforce Amid Scandal
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
SK Hynix Shares Fall as Workers Reject Wage Deal
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Luxshare Shares Rise as First-Half Profit Jumps 18%
California Seeks Paramount Divestitures in Warner Bros. Merger
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 



